The first head-to-head comparison of 3 similar frontline drugs for advanced breast cancer reveals important differences in biological activityhttp://hvrd.me/n84T30poTIq
0 replies
10 retweets
17 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.